Lyra Therapeutics Inc Share Price Today: Live Updates & Key Insights
Lyra Therapeutics Inc share price today is $0.3572, up -62.5%. The stock opened at $1.25 against the previous close of $1.32, with an intraday high of $1.25 and low of $0.4847.
Lyra Therapeutics Inc Share Price Chart
Lyra Therapeutics Inc
Lyra Therapeutics Inc Share Price Performance
Lyra Therapeutics Inc Institutional Holdings
Lyra Therapeutics Inc Market Status
Lyra Therapeutics Inc Fundamentals
Market Cap 2.34 M
PB Ratio 3.9033
PE Ratio 0.0
Enterprise Value 11.67 M
Total Assets 66.35 M
Volume 1396144
Lyra Therapeutics Inc Company Financials
About Lyra Therapeutics Inc & investment objective
Company Information Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix which is in Phase III clinical trial for the treatment of chronic rhinosinusitis (CRS); and LYR-220 for CRS patients who have failed previous medical management and continue to require treatment to manage CRS symptoms. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.
Organisation Biotechnology
Employees 30
Industry Biotechnology
CEO null
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Lyra Therapeutics Inc FAQs
What is the share price of Lyra Therapeutics Inc today?
The current share price of Lyra Therapeutics Inc is $0.3572.
Can I buy Lyra Therapeutics Inc shares in India?
Yes, Indian investors can buy Lyra Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Lyra Therapeutics Inc shares in India?
You can easily invest in Lyra Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Lyra Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Lyra Therapeutics Inc.
Can I buy fractional shares of Lyra Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Lyra Therapeutics Inc?
Lyra Therapeutics Inc has a market cap of $2.34 M.
In which sector does Lyra Therapeutics Inc belong?
Lyra Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Lyra Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Lyra Therapeutics Inc?
The PE ratio of Lyra Therapeutics Inc is N/A and the PB ratio is 3.90.